Cargando…
Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor
Desmoplastic small round cell tumor (DSRCT) is a rare pediatric cancer caused by the EWSR1-WT1 fusion oncogene. Despite initial response to chemotherapy, DSRCT has a recurrence rate of over 80% leading to poor patient prognosis with a 5-year survival rate of only 15–25%. Owing to the rarity of DSRCT...
Autores principales: | Magrath, Justin W., Flinchum, Dane A., Hartono, Alifiani B., Goldberg, Ilon N., Espinosa-Cotton, Madelyn, Moroz, Krzysztof, Cheung, Nai-Kong V., Lee, Sean B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344636/ https://www.ncbi.nlm.nih.gov/pubmed/37457440 http://dx.doi.org/10.1155/2023/6686702 |
Ejemplares similares
-
Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein
por: Magrath, Justin W., et al.
Publicado: (2022) -
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2021) -
Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2023) -
Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor
por: Hartono, Alifiani Bonita, et al.
Publicado: (2022) -
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
por: Smith, Roger S., et al.
Publicado: (2022)